Warning: The NCBI web site requires JavaScript to function. more...
96 shRNAs designed for maximal coverage of HIV-1 variants.
McIntyre GJ, Groneman JL, Yu YH, Jaramillo A, Shen S, Applegate TL.
Retrovirology. 2009 Jun 4;6:55.
Related citations
Stringent testing identifies highly potent and escape-proof anti-HIV short hairpin RNAs.
von Eije KJ, ter Brake O, Berkhout B.
J Gene Med. 2009 Jun;11(6):459-67.
Silencing of HIV-1 with RNA interference: a multiple shRNA approach.
ter Brake O, Konstantinova P, Ceylan M, Berkhout B.
Mol Ther. 2006 Dec;14(6):883-92. Epub 2006 Sep 7.
Design of extended short hairpin RNAs for HIV-1 inhibition.
Liu YP, Haasnoot J, Berkhout B.
Nucleic Acids Res. 2007;35(17):5683-93. Epub 2007 Aug 21.
Silencing of HIV-1 subtype C primary isolates by expressed small hairpin RNAs targeted to gag.
Cave E, Weinberg MS, Cilliers T, Carmona S, Morris L, Arbuthnot P.
AIDS Res Hum Retroviruses. 2006 May;22(5):401-10.
Effective suppression of human immunodeficiency virus type 1 through a combination of short- or long-hairpin RNAs targeting essential sequences for retroviral integration.
Nishitsuji H, Kohara M, Kannagi M, Masuda T.
J Virol. 2006 Aug;80(15):7658-66.
Combinatorial RNAi against HIV-1 using extended short hairpin RNAs.
Liu YP, von Eije KJ, Schopman NC, Westerink JT, ter Brake O, Haasnoot J, Berkhout B.
Mol Ther. 2009 Oct;17(10):1712-23. Epub 2009 Aug 11.
Nucleotide sequence homology requirements of HIV-1-specific short hairpin RNA.
Pusch O, Boden D, Silbermann R, Lee F, Tucker L, Ramratnam B.
Nucleic Acids Res. 2003 Nov 15;31(22):6444-9.
The inhibitory efficacy of RNA POL III-expressed long hairpin RNAs targeted to untranslated regions of the HIV-1 5' long terminal repeat.
Barichievy S, Saayman S, von Eije KJ, Morris KV, Arbuthnot P, Weinberg MS.
Oligonucleotides. 2007 Winter;17(4):419-31.
Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
ter Brake O, Berkhout B.
J Gene Med. 2007 Sep;9(9):743-50.
The virion-associated incoming HIV-1 RNA genome is not targeted by RNA interference.
Westerhout EM, ter Brake O, Berkhout B.
Retrovirology. 2006 Sep 4;3:57.
RNAi as a treatment for HIV-1 infection.
Rossi JJ.
Biotechniques. 2006 Apr;Suppl:25-9. Review.
Multiple shRNA combinations for near-complete coverage of all HIV-1 strains.
McIntyre GJ, Groneman JL, Yu YH, Tran A, Applegate TL.
AIDS Res Ther. 2011 Jan 13;8(1):1.
Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin RNA.
Konstantinova P, de Vries W, Haasnoot J, ter Brake O, de Haan P, Berkhout B.
Gene Ther. 2006 Oct;13(19):1403-13. Epub 2006 May 18.
Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition.
ter Brake O, 't Hooft K, Liu YP, Centlivre M, von Eije KJ, Berkhout B.
Mol Ther. 2008 Mar;16(3):557-64. Epub 2008 Jan 15.
shRNAs targeting hepatitis C: effects of sequence and structural features, and comparision with siRNA.
Vlassov AV, Korba B, Farrar K, Mukerjee S, Seyhan AA, Ilves H, Kaspar RL, Leake D, Kazakov SA, Johnston BH.
Oligonucleotides. 2007 Summer;17(2):223-36.
Construction of simple and efficient DNA vector-based short hairpin RNA expression systems for specific gene silencing in mammalian cells.
Cheng TL, Chang WT.
Methods Mol Biol. 2007;408:223-41.
A quick and efficient approach for gene silencing by using triple putative microRNA-based short hairpin RNAs.
Shan ZX, Lin QX, Yang M, Deng CY, Kuang SJ, Zhou ZL, Xiao DZ, Liu XY, Lin SG, Yu XY.
Mol Cell Biochem. 2009 Mar;323(1-2):81-9. Epub 2008 Nov 27.
Control of HIV-1 replication by RNA interference.
Lee NS, Rossi JJ.
Virus Res. 2004 Jun 1;102(1):53-8. Review.
Selection of potent non-toxic inhibitory sequences from a randomized HIV-1 specific lentiviral short hairpin RNA library.
Pongratz C, Yazdanpanah B, Kashkar H, Lehmann MJ, Kräusslich HG, Krönke M.
PLoS One. 2010 Oct 8;5(10):e13172.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on